XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2020
Stockholders' Equity (Tables) [Line Items]  
Schedule of warrant and stock option grants
   Warrant Grants   Stock Option Grants   Restricted Stock Units 
   Number of shares subject to warrants   Weighted-average exercise price per share   Number of shares subject to options   Weighted-average exercise price per share   Number of shares subject to restricted stock units   Weighted-average exercise price per share 
Balance at December 31, 2019   1,311,916   $9.35    338,595   $5.96    630,303   $          - 
Granted   -    -    -    -    395,000    - 
Exercised   -    -    -    -    -    - 
Cancelled/Forfeited   -    -    -    -    (250,000)   - 
Balance at March 31, 2020   1,311,916   $9.35    338,595   $5.96    775,303   $- 
Exercisable at March 31, 2020   1,311,916   $9.35    338,595   $5.96    

41,667

   $- 
Schedule of stock-based compensation expense categorized of equity components
   For the three months ended 
   March 31, 
   2020   2019 
Common stock  $367,600   $257,885 
Stock option awards   -    49,018 
Transfer of common stock by founders to contractors   -    5,322,930 
Total  $367,600   $5,629,833 
Stock Options [Member]  
Stockholders' Equity (Tables) [Line Items]  
Schedule of stock-based compensation expense
   For the three months ended 
   March 31, 
   2020   2019 
Stock-based compensation expense  $367,600   $5,629,833